Once-a-day therapy of cefpodoxime proxetil for respiratory tract infections. 1995

Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
School of Health Sciences, and First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D012141 Respiratory Tract Infections Invasion of the host RESPIRATORY SYSTEM by microorganisms, usually leading to pathological processes or diseases. Respiratory System Infections,Upper Respiratory Tract Infection,Upper Respiratory Tract Infections,Infections, Respiratory,Infections, Respiratory Tract,Infections, Upper Respiratory,Infections, Upper Respiratory Tract,Respiratory Infections,Upper Respiratory Infections,Infection, Respiratory System,Infection, Respiratory Tract,Respiratory Infection, Upper,Respiratory System Infection,Respiratory Tract Infection
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000097627 Cefpodoxime Proxetil A prodrug of its active metabolite CEFPODOXIME. 1-(Isopropoxycarbonyloxy)ethyl-7-(2-(2-Amino-4-thiazolyl)-2-(Methoxyimino)Acetamido)-3-Methoxymethyl-8-oxo-5-thia-1-Azabicyclo(4,2,0)-oct-2-ene-2-Carboxylate,Cephalosporin 807,Orelox,Otreon,U-76252,CS 807,CS-807,U 76252,Vantin,76252, U,807, CS,807, Cephalosporin,Proxetil, Cefpodoxime,U76252
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
January 1991, Drugs,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
October 1988, The Japanese journal of antibiotics,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
January 1991, Drugs,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
December 1990, The Journal of antimicrobial chemotherapy,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
October 1984, The American journal of medicine,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
February 2000, MMW Fortschritte der Medizin,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
December 1990, The Journal of antimicrobial chemotherapy,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
January 2019, Profiles of drug substances, excipients, and related methodology,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
March 1993, Pediatric annals,
Y Sawae, and K Ninomiya, and I Sumida, and T Inoue, and K Takaki, and K Okada, and Y Kumagai, and T Ishimaru, and N Shimono, and H Misumi
August 1996, PharmacoEconomics,
Copied contents to your clipboard!